List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 114 studies with search of: LAM
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)
Condition: Leiomyomatosis
Intervention:
2 Recruiting Doxycycline In Lymphangioleiomyomatosis (LAM)
Conditions: Lymphangioleiomyomatosis;   Tuberous Sclerosis
Interventions: Drug: Doxycycline;   Drug: Placebo
3 Completed Treatment With Octreotide in Patients With Lymphangioleiomyomatosis
Conditions: Lymphangioleiomyomatosis;   Lymphangiomyomatosis
Intervention: Drug: Octreotide
4 Active, not recruiting Efficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM)
Condition: Lymphangioleiomyomatosis
Interventions: Drug: Sirolimus;   Drug: Placebo sirolimus
5 Recruiting Pulmonary Hypertension in Lymphangioleiomyomatosis
Conditions: Lymphangioleiomyomatosis;   Pulmonary Hypertension
Intervention:
6 Completed Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM
Conditions: Tuberous Sclerosis;   Lymphangioleiomyomatosis
Intervention: Drug: Rapamycin, sirolimus
7 Recruiting Study of the Disease Process of Lymphangioleiomyomatosis
Conditions: Lung Disease;   Pneumothorax;   Tuberous Sclerosis
Intervention:
8 Recruiting Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
Conditions: Tuberous Sclerosis;   Subependymal Giant Cell Astrocytoma
Interventions: Drug: Everolimus (RAD001);   Other: Placebo
9 Active, not recruiting Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM
Conditions: Tuberous Sclerosis;   Lymphangioleiomyomatosis
Intervention: Drug: sirolimus
10 Recruiting Lipoarabinomannan (LAM) Enzyme-Linked Immunosorbent Assay (ELISA) in Diagnostics of Childhood Tuberculosis (TB)
Condition: Tuberculosis
Intervention:
11 Completed Lymphangioleiomyomatosis (LAM) Registry
Conditions: Lung Diseases;   Lymphangiomyomatosis
Intervention:
12 Enrolling by invitation Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)
Conditions: Tuberous Sclerosis;   Angiolipoma
Intervention: Drug: everolimus (RAD001)
13 Recruiting Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women
Conditions: Lymphangioleiomyomas;   Tuberous Sclerosis;   Lymphangioleiomyomatosis
Intervention:
14 Recruiting RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM
Conditions: Tuberous Sclerosis;   Lymphangioleiomyomatosis
Intervention: Drug: RAD001
15 Completed Leprosy Skin Test Antigens Trial
Condition: Leprosy
Interventions: Drug: MLCwA;   Drug: MLSA-LAM;   Drug: Placebo;   Drug: Tuberculin, Purified Protein Derivative (Tubersol®);   Drug: RT-23
16 Completed A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in Previous Studies Defined by the Protocol.
Condition: Kidney Failure, Chronic
Intervention: Drug: Lanthanum carbonate
17 Recruiting Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Liver Cancer
Interventions: Procedure: RFA;   Drug: lamivudine or entecavir
18 Completed Pediatric Epilepsy Study in Subjects 1-24 Months
Condition: Epilepsy
Intervention: Drug: lamotrigine
19 Completed AML Treatment in Untreated Adult Patients
Condition: Leukemia, Myelocytic, Acute
Interventions: Procedure: Identification of appropriate therapies according to risks factors;   Drug: Daunorubicine;   Procedure: Transplant
20 Completed Maintenance Treatment of Bipolar Depression
Conditions: Bipolar Disorder;   Depression
Interventions: Drug: Lamotrigine (LAM);   Drug: Divalproex (DIV);   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services